Atomistry » Chlorine » PDB 5ti4-5tr9 » 5tno
Atomistry »
  Chlorine »
    PDB 5ti4-5tr9 »
      5tno »

Chlorine in PDB 5tno: Discovery of Novel Aminobenzisoxazole Derivatives As Orally Available Factor Ixa Inhibitors

Enzymatic activity of Discovery of Novel Aminobenzisoxazole Derivatives As Orally Available Factor Ixa Inhibitors

All present enzymatic activity of Discovery of Novel Aminobenzisoxazole Derivatives As Orally Available Factor Ixa Inhibitors:
3.4.21.22;

Protein crystallography data

The structure of Discovery of Novel Aminobenzisoxazole Derivatives As Orally Available Factor Ixa Inhibitors, PDB code: 5tno was solved by I.Sakurada, T.Endo, K.Hikita, T.Hirabayashi, Y.Hosaka, Y.Kato, Y.Maeda, S.Matsumoto, T.Mizuno, H.Nagasue, T.Nishimura, S.Shimada, M.Shinozaki, K.Taguchi, K.Takeuchi, T.Yokoyama, A.Hruza, P.Reichert, T.Zhang, H.B.Wood, K.Nakao, S.Furusako, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 22.55 / 1.54
Space group H 3
Cell size a, b, c (Å), α, β, γ (°) 98.835, 98.835, 94.252, 90.00, 90.00, 120.00
R / Rfree (%) 14.5 / 15.8

Other elements in 5tno:

The structure of Discovery of Novel Aminobenzisoxazole Derivatives As Orally Available Factor Ixa Inhibitors also contains other interesting chemical elements:

Sodium (Na) 1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Discovery of Novel Aminobenzisoxazole Derivatives As Orally Available Factor Ixa Inhibitors (pdb code 5tno). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Discovery of Novel Aminobenzisoxazole Derivatives As Orally Available Factor Ixa Inhibitors, PDB code: 5tno:

Chlorine binding site 1 out of 1 in 5tno

Go back to Chlorine Binding Sites List in 5tno
Chlorine binding site 1 out of 1 in the Discovery of Novel Aminobenzisoxazole Derivatives As Orally Available Factor Ixa Inhibitors


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Discovery of Novel Aminobenzisoxazole Derivatives As Orally Available Factor Ixa Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl301

b:55.7
occ:1.00
CL A:UNL301 0.0 55.7 1.0
C16 A:UNL301 1.7 45.3 1.0
C15 A:UNL301 2.7 42.3 1.0
C11 A:UNL301 2.7 44.0 1.0
H11 A:UNL301 2.8 39.1 1.0
H6 A:UNL301 2.8 41.1 1.0
HB2 A:TRP215 2.8 27.9 1.0
HH A:TYR99 3.0 49.6 1.0
H18 A:UNL301 3.1 40.2 1.0
N1 A:UNL301 3.1 40.6 1.0
C10 A:UNL301 3.1 44.5 1.0
OH A:TYR99 3.3 50.1 1.0
H A:GLY216 3.5 27.8 1.0
CZ A:TYR99 3.7 47.8 1.0
O A:GLY216 3.7 33.4 1.0
C6 A:UNL301 3.7 39.1 1.0
H10 A:UNL301 3.8 40.4 1.0
CB A:TRP215 3.8 25.6 1.0
HB3 A:TRP215 3.8 26.3 1.0
HE1 A:TYR99 3.9 40.6 1.0
CE1 A:TYR99 3.9 40.7 1.0
C14 A:UNL301 4.0 43.6 1.0
C12 A:UNL301 4.0 45.9 1.0
O A:UNL301 4.0 44.7 1.0
C7 A:UNL301 4.1 39.3 1.0
HE3 A:TRP215 4.2 28.8 1.0
HA A:TRP215 4.2 23.8 1.0
C8 A:UNL301 4.2 39.4 1.0
H5 A:UNL301 4.3 29.3 1.0
N A:UNL301 4.3 32.7 1.0
CE2 A:TYR99 4.4 44.2 1.0
N A:GLY216 4.5 27.4 1.0
C13 A:UNL301 4.5 45.6 1.0
H12 A:UNL301 4.5 39.5 1.0
C5 A:UNL301 4.6 27.5 1.0
CA A:TRP215 4.6 24.7 1.0
C4 A:UNL301 4.6 28.5 1.0
HE2 A:TYR99 4.7 45.0 1.0
CG A:TRP215 4.8 26.9 1.0
C9 A:UNL301 4.8 36.8 1.0
C A:GLY216 4.9 33.6 1.0
CD1 A:TYR99 4.9 40.8 1.0
H3 A:UNL301 4.9 46.7 1.0
CE3 A:TRP215 4.9 29.1 1.0

Reference:

I.Sakurada, T.Endo, K.Hikita, T.Hirabayashi, Y.Hosaka, Y.Kato, Y.Maeda, S.Matsumoto, T.Mizuno, H.Nagasue, T.Nishimura, S.Shimada, M.Shinozaki, K.Taguchi, K.Takeuchi, T.Yokoyama, A.Hruza, P.Reichert, T.Zhang, H.B.Wood, K.Nakao, S.Furusako. Discovery of Novel Aminobenzisoxazole Derivatives As Orally Available Factor Ixa Inhibitors. Bioorg. Med. Chem. Lett. V. 27 2622 2017.
ISSN: ESSN 1464-3405
PubMed: 28408226
DOI: 10.1016/J.BMCL.2017.03.002
Page generated: Fri Jul 26 17:33:28 2024

Last articles

Cl in 3WMP
Cl in 3WNH
Cl in 3WNR
Cl in 3WNG
Cl in 3WNF
Cl in 3WNE
Cl in 3WN2
Cl in 3WMQ
Cl in 3WN1
Cl in 3WN0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy